About Adwia Pharmaceuticals
Adwia Pharmaceuticals is a company based in Cairo (Egypt) founded in 1984 was acquired by EBRD in November 2020. Adwia Pharmaceuticals offers products and services including Generic Medicines and Animal Health Products.
- Headquarter Cairo, Egypt
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Adwia Pharmaceuticals
Adwia Pharmaceuticals offers a comprehensive portfolio of products and services, including Generic Medicines and Animal Health Products.
Provides generic drugs for human health in various therapeutic categories
Offers medicines for animal health and infection control needs
People of Adwia Pharmaceuticals
Unlock access to complete
Funding Insights of Adwia Pharmaceuticals
Detailed funding history for Adwia Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Adwia Pharmaceuticals
Adwia Pharmaceuticals has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include EBRD, British International Investment and DPI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate advisory services are provided across multiple sectors.
|
Locked | Locked | Locked | |
|
Government agency focused on small and medium-sized businesses
|
Locked | Locked | Locked | |
|
A premier African investment firm focused on high-growth businesses.
|
Locked | Locked | Locked |
Investor details for Adwia Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Adwia Pharmaceuticals
Investment portfolio details for Adwia Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Adwia Pharmaceuticals
Detailed financials for Adwia Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adwia Pharmaceuticals Comparisons
Peer comparison for Adwia Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Adwia Pharmaceuticals
Detailed competitors of Adwia Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adwia Pharmaceuticals
Complete news archive for Adwia Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adwia Pharmaceuticals
Adwia Pharmaceuticals was founded in 1984.
Adwia Pharmaceuticals is headquartered in Cairo, Egypt.
Developer of drugs for treating multiple diseases. The companys proprietary platform aims to develop human and veterinary medications for multiple health disorders. It has developed Adwiprill tablets for treating antihypertensives cardiovascular diseases. It also offers myogrel tablets for antiplatelets, intranox capsules, dinar antibiotics for treating infectious diseases, bronchofreee capsules for respiratory systems, inocont tablets for urinary tract infections, nopecia for dermatology, tibolone tablets for gynecology treatments. The platform also provides veterinary medicines such as antibiotics chemotherapeutics, analgesics, anthelmintics, anti-coccidiosis anti-protozoal, antifungals, and many more.
Adwia Pharmaceuticals offers Generic Medicines and Animal Health Products.
Adwia Pharmaceuticals has 3 investors. Key investors include EBRD, British International Investment, and DPI.